| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.01e-05 | 11 | 101 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 2.01e-05 | 11 | 101 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.79e-05 | 70 | 101 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRPM7 PDK3 PSKH1 PFKFB2 SIRT6 TRRAP POLR3A PHKA1 BMPR1B ART3 PIK3C3 PIK3CB BUB1 ATM MAB21L1 | 7.25e-05 | 938 | 101 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.70e-05 | 18 | 101 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | kinesin binding | 1.73e-04 | 55 | 101 | 4 | GO:0019894 | |
| GeneOntologyMolecularFunction | type 2 fibroblast growth factor receptor binding | 2.51e-04 | 5 | 101 | 2 | GO:0005111 | |
| GeneOntologyMolecularFunction | phosphatidylinositol kinase activity | 3.00e-04 | 26 | 101 | 3 | GO:0052742 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.34e-04 | 118 | 101 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | type 1 fibroblast growth factor receptor binding | 3.75e-04 | 6 | 101 | 2 | GO:0005105 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.75e-04 | 28 | 101 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.00e-04 | 441 | 101 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | NAD+-protein-arginine ADP-ribosyltransferase activity | 5.23e-04 | 7 | 101 | 2 | GO:0106274 | |
| GeneOntologyMolecularFunction | prolactin receptor binding | 5.23e-04 | 7 | 101 | 2 | GO:0005148 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.60e-04 | 32 | 101 | 3 | GO:0099186 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.61e-04 | 37 | 101 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | Tat protein binding | 1.11e-03 | 10 | 101 | 2 | GO:0030957 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 1.11e-03 | 10 | 101 | 2 | GO:0005131 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 1.16e-03 | 41 | 101 | 3 | GO:0001727 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.25e-03 | 42 | 101 | 3 | GO:0098918 | |
| GeneOntologyMolecularFunction | kinase activity | TRPM7 PDK3 PSKH1 PFKFB2 TRRAP PHKA1 BMPR1B PIK3C3 PIK3CB BUB1 ATM | 1.66e-03 | 764 | 101 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.92e-03 | 446 | 101 | 8 | GO:0004674 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.22e-03 | 14 | 101 | 2 | GO:0008401 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 8.60e-05 | 95 | 97 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 8.60e-05 | 95 | 97 | 5 | GO:2000781 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 9.97e-05 | 98 | 97 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIFBP DNAH10 CATSPERD KIF1B ACTR2 FSIP2 IFT88 DNAH8 DYNC1H1 KIF1C | 1.09e-04 | 493 | 97 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.10e-04 | 100 | 97 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.26e-04 | 103 | 97 | 5 | GO:0044784 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 1.31e-04 | 4 | 97 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 1.46e-04 | 22 | 97 | 3 | GO:0036092 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.79e-04 | 111 | 97 | 5 | GO:0033045 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 1.90e-04 | 24 | 97 | 3 | GO:0008090 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.73e-05 | 32 | 102 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.73e-05 | 32 | 102 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 2.52e-05 | 317 | 102 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | cytoplasmic region | 6.76e-05 | 360 | 102 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 6.83e-05 | 45 | 102 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EFCAB6 NCKAP1 DNAH10 ACTBL2 KIF1B ACTB ACTG1 TRIP10 FAM83H CCT6A DNAH8 PTPN20 DYNC1H1 KIF1C | 1.18e-04 | 899 | 102 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | growth hormone receptor complex | 3.49e-04 | 6 | 102 | 2 | GO:0070195 | |
| GeneOntologyCellularComponent | dense body | 4.87e-04 | 7 | 102 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | axoneme | 5.36e-04 | 207 | 102 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.50e-04 | 208 | 102 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | calyx of Held | 7.16e-04 | 36 | 102 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | bBAF complex | 1.03e-03 | 10 | 102 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | chromosomal region | 1.07e-03 | 421 | 102 | 8 | GO:0098687 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.16e-03 | 161 | 102 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.16e-03 | 94 | 102 | 4 | GO:0000123 | |
| GeneOntologyCellularComponent | microtubule | 1.19e-03 | 533 | 102 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | endosome lumen | 1.21e-03 | 43 | 102 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.69e-03 | 104 | 102 | 4 | GO:0031248 | |
| GeneOntologyCellularComponent | supramolecular fiber | EFCAB6 NCKAP1 DNAH10 ACTBL2 KIF1B ACTB ACTG1 TRIP10 FAM83H CCT6A DNAH8 PTPN20 DYNC1H1 KIF1C | 1.74e-03 | 1179 | 102 | 14 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EFCAB6 NCKAP1 DNAH10 ACTBL2 KIF1B ACTB ACTG1 TRIP10 FAM83H CCT6A DNAH8 PTPN20 DYNC1H1 KIF1C | 1.85e-03 | 1187 | 102 | 14 | GO:0099081 |
| GeneOntologyCellularComponent | kinetochore | 1.95e-03 | 181 | 102 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.01e-03 | 109 | 102 | 4 | GO:1902493 | |
| GeneOntologyCellularComponent | npBAF complex | 2.06e-03 | 14 | 102 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | GBAF complex | 2.06e-03 | 14 | 102 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | dynein complex | 2.34e-03 | 54 | 102 | 3 | GO:0030286 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.35e-03 | 276 | 102 | 6 | GO:0000775 | |
| GeneOntologyCellularComponent | RSC-type complex | 2.38e-03 | 15 | 102 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.57e-03 | 193 | 102 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | nBAF complex | 2.71e-03 | 16 | 102 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 3.43e-03 | 18 | 102 | 2 | GO:0120212 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 3.82e-03 | 19 | 102 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | axon | SLC4A8 TRPM7 ACTBL2 KIF1B ACTB ACTG1 GDI1 ADORA1 LRP2 DYNC1H1 KIF1C | 4.13e-03 | 891 | 102 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | axon cytoplasm | 4.49e-03 | 68 | 102 | 3 | GO:1904115 | |
| Domain | Actin/actin-like_CS | 3.22e-08 | 18 | 100 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 4.36e-08 | 19 | 100 | 5 | PS01132 | |
| Domain | Actin | 6.05e-07 | 31 | 100 | 5 | IPR004000 | |
| Domain | Actin | 6.05e-07 | 31 | 100 | 5 | PF00022 | |
| Domain | ACTIN | 6.05e-07 | 31 | 100 | 5 | SM00268 | |
| Domain | - | 1.34e-06 | 16 | 100 | 4 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.34e-06 | 16 | 100 | 4 | SM00146 | |
| Domain | PI3_PI4_kinase | 2.23e-06 | 18 | 100 | 4 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.23e-06 | 18 | 100 | 4 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.23e-06 | 18 | 100 | 4 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 2.23e-06 | 18 | 100 | 4 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 2.23e-06 | 18 | 100 | 4 | PS50290 | |
| Domain | DHC_N1 | 8.18e-06 | 8 | 100 | 3 | PF08385 | |
| Domain | ACTINS_1 | 8.18e-06 | 8 | 100 | 3 | PS00406 | |
| Domain | Dynein_heavy_dom-1 | 8.18e-06 | 8 | 100 | 3 | IPR013594 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-05 | 14 | 100 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-05 | 14 | 100 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-05 | 14 | 100 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.19e-05 | 14 | 100 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.19e-05 | 14 | 100 | 3 | IPR011704 | |
| Domain | MT | 5.19e-05 | 14 | 100 | 3 | PF12777 | |
| Domain | AAA_8 | 5.19e-05 | 14 | 100 | 3 | PF12780 | |
| Domain | AAA_5 | 5.19e-05 | 14 | 100 | 3 | PF07728 | |
| Domain | DHC_fam | 6.47e-05 | 15 | 100 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 6.47e-05 | 15 | 100 | 3 | PF03028 | |
| Domain | PI3/4_kinase_CS | 6.47e-05 | 15 | 100 | 3 | IPR018936 | |
| Domain | Dynein_heavy_dom | 6.47e-05 | 15 | 100 | 3 | IPR004273 | |
| Domain | Actin_CS | 7.93e-05 | 16 | 100 | 3 | IPR004001 | |
| Domain | ACTINS_2 | 9.59e-05 | 17 | 100 | 3 | PS00432 | |
| Domain | Somatotropin_CS | 2.81e-04 | 5 | 100 | 2 | IPR018116 | |
| Domain | Mab-21-like_1/2 | 2.81e-04 | 5 | 100 | 2 | IPR020950 | |
| Domain | Kinesin_assoc | 4.20e-04 | 6 | 100 | 2 | PF16183 | |
| Domain | SOMATOTROPIN_2 | 4.20e-04 | 6 | 100 | 2 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 4.20e-04 | 6 | 100 | 2 | PS00266 | |
| Domain | FAT | 4.20e-04 | 6 | 100 | 2 | PS51189 | |
| Domain | FATC | 4.20e-04 | 6 | 100 | 2 | PS51190 | |
| Domain | Hormone_1 | 4.20e-04 | 6 | 100 | 2 | PF00103 | |
| Domain | Kinesin_assoc | 4.20e-04 | 6 | 100 | 2 | IPR032405 | |
| Domain | FAT | 4.20e-04 | 6 | 100 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 4.20e-04 | 6 | 100 | 2 | IPR003151 | |
| Domain | FATC_dom | 4.20e-04 | 6 | 100 | 2 | IPR003152 | |
| Domain | PIK_FAT | 4.20e-04 | 6 | 100 | 2 | IPR014009 | |
| Domain | FATC | 4.20e-04 | 6 | 100 | 2 | SM01343 | |
| Domain | Somatotropin | 5.86e-04 | 7 | 100 | 2 | IPR001400 | |
| Domain | PI3K_C2 | 7.78e-04 | 8 | 100 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 7.78e-04 | 8 | 100 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 7.78e-04 | 8 | 100 | 2 | PF00792 | |
| Domain | PI3K_C2 | 7.78e-04 | 8 | 100 | 2 | PS51547 | |
| Domain | PI3Ka | 9.97e-04 | 9 | 100 | 2 | PF00613 | |
| Domain | PI3Ka | 9.97e-04 | 9 | 100 | 2 | SM00145 | |
| Domain | - | 9.97e-04 | 9 | 100 | 2 | 1.25.40.70 | |
| Domain | PI_Kinase | 1.24e-03 | 10 | 100 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 1.24e-03 | 10 | 100 | 2 | IPR001263 | |
| Domain | PIK_HELICAL | 1.24e-03 | 10 | 100 | 2 | PS51545 | |
| Domain | Mab-21 | 1.81e-03 | 12 | 100 | 2 | PF03281 | |
| Domain | Mab-21 | 1.81e-03 | 12 | 100 | 2 | SM01265 | |
| Domain | Mab-21_dom | 1.81e-03 | 12 | 100 | 2 | IPR024810 | |
| Domain | SMAD_FHA_domain | 2.72e-03 | 52 | 100 | 3 | IPR008984 | |
| Domain | PTPc_motif | 3.90e-03 | 59 | 100 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.90e-03 | 59 | 100 | 3 | IPR003595 | |
| Domain | DSRM | 4.57e-03 | 19 | 100 | 2 | SM00358 | |
| Domain | dsrm | 5.06e-03 | 20 | 100 | 2 | PF00035 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 4.57e-07 | 29 | 77 | 5 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 5.46e-07 | 30 | 77 | 5 | M47738 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 3.73e-06 | 20 | 77 | 4 | M47737 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 9.54e-06 | 25 | 77 | 4 | M47716 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.06e-05 | 257 | 77 | 9 | MM14755 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.73e-05 | 150 | 77 | 7 | M39520 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 1.83e-05 | 10 | 77 | 3 | M47575 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.89e-05 | 152 | 77 | 7 | MM15834 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 3.37e-05 | 34 | 77 | 4 | MM15265 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 4.24e-05 | 36 | 77 | 4 | M27549 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY | 4.31e-05 | 13 | 77 | 3 | M47723 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY | 4.31e-05 | 13 | 77 | 3 | M47730 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CCP110 CENPT NCKAP1 CENPF ACTB ACTG1 MTMR1 TRIP10 ACTR2 CCT6A PIK3C3 BUB1 DYNC1H1 | 4.48e-05 | 649 | 77 | 13 | MM15690 |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY | 5.46e-05 | 14 | 77 | 3 | M47729 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY | 5.46e-05 | 14 | 77 | 3 | M47726 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 6.39e-05 | 323 | 77 | 9 | M27080 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 7.15e-05 | 41 | 77 | 4 | MM14505 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 1.01e-04 | 17 | 77 | 3 | M47728 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.15e-04 | 140 | 77 | 6 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.19e-04 | 141 | 77 | 6 | MM15266 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 1.23e-04 | 47 | 77 | 4 | MM14885 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CCP110 CENPT NCKAP1 CENPF ACTB ACTG1 MTMR1 TRIP10 ACTR2 CCT6A PIK3C3 BUB1 DYNC1H1 | 1.28e-04 | 720 | 77 | 13 | M41838 |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 1.33e-04 | 48 | 77 | 4 | M26916 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 1.33e-04 | 48 | 77 | 4 | MM15441 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 1.94e-04 | 21 | 77 | 3 | M47722 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 2.12e-04 | 54 | 77 | 4 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 2.12e-04 | 54 | 77 | 4 | M620 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 2.27e-04 | 55 | 77 | 4 | M11844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 2.91e-04 | 5 | 77 | 2 | M49034 | |
| Pathway | BIOCARTA_AKT_PATHWAY | 3.72e-04 | 26 | 77 | 3 | MM1345 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 3.78e-04 | 113 | 77 | 5 | MM14783 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.94e-04 | 114 | 77 | 5 | MM14814 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.95e-04 | 326 | 77 | 8 | MM15917 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 4.26e-04 | 116 | 77 | 5 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 4.44e-04 | 117 | 77 | 5 | M39530 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 4.61e-04 | 118 | 77 | 5 | M39852 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 4.61e-04 | 118 | 77 | 5 | M713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE | 5.72e-04 | 30 | 77 | 3 | M47889 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 6.08e-04 | 7 | 77 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 6.08e-04 | 7 | 77 | 2 | M47845 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 6.08e-04 | 7 | 77 | 2 | M27064 | |
| Pathway | REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION | 6.08e-04 | 7 | 77 | 2 | MM14726 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 6.31e-04 | 31 | 77 | 3 | M47396 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 6.73e-04 | 73 | 77 | 4 | M39837 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 7.60e-04 | 33 | 77 | 3 | M27297 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 7.84e-04 | 76 | 77 | 4 | MM15442 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 9.04e-04 | 35 | 77 | 3 | M16801 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 9.04e-04 | 35 | 77 | 3 | M47969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 1.03e-03 | 9 | 77 | 2 | M47844 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.03e-03 | 9 | 77 | 2 | M39819 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.03e-03 | 9 | 77 | 2 | M47725 | |
| Pathway | REACTOME_SIGNALING_BY_INSULIN_RECEPTOR | 1.04e-03 | 82 | 77 | 4 | M1021 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.07e-03 | 37 | 77 | 3 | MM15022 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY | 1.07e-03 | 37 | 77 | 3 | M47769 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.07e-03 | 142 | 77 | 5 | MM15499 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 1.08e-03 | 213 | 77 | 6 | M18306 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.10e-03 | 143 | 77 | 5 | M27107 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.17e-03 | 145 | 77 | 5 | M27753 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.29e-03 | 10 | 77 | 2 | MM1532 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.29e-03 | 10 | 77 | 2 | MM15112 | |
| Pathway | REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC | 1.29e-03 | 10 | 77 | 2 | M27299 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 1.44e-03 | 41 | 77 | 3 | MM15630 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.54e-03 | 42 | 77 | 3 | M27308 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.57e-03 | 11 | 77 | 2 | MM14732 | |
| Pathway | REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL | 1.65e-03 | 43 | 77 | 3 | M27602 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.88e-03 | 12 | 77 | 2 | M15243 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 1.88e-03 | 12 | 77 | 2 | MM14728 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.88e-03 | 12 | 77 | 2 | M22006 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 2.14e-03 | 47 | 77 | 3 | M39518 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 2.17e-03 | 100 | 77 | 4 | MM14561 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 2.21e-03 | 13 | 77 | 2 | M27540 | |
| Pathway | REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING | 2.21e-03 | 13 | 77 | 2 | MM15262 | |
| Pathway | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | 2.21e-03 | 13 | 77 | 2 | M1087 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 2.21e-03 | 13 | 77 | 2 | M27061 | |
| Pathway | REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION | 2.21e-03 | 13 | 77 | 2 | MM14723 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.21e-03 | 13 | 77 | 2 | MM14516 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 2.41e-03 | 49 | 77 | 3 | M40046 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.42e-03 | 103 | 77 | 4 | MM14752 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.49e-03 | 339 | 77 | 7 | M39736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.57e-03 | 14 | 77 | 2 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 2.57e-03 | 14 | 77 | 2 | M47536 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.68e-03 | 106 | 77 | 4 | M27077 | |
| Pathway | WP_THERMOGENESIS | 2.87e-03 | 108 | 77 | 4 | M39746 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 2.95e-03 | 15 | 77 | 2 | M27509 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.95e-03 | 15 | 77 | 2 | M552 | |
| Pathway | REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4 | 2.95e-03 | 15 | 77 | 2 | MM15235 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.17e-03 | 111 | 77 | 4 | M27673 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CCP110 KIFBP NCKAP1 RBL1 ACTBL2 KIF1B TM9SF3 PFKFB2 GDI1 PGM3 IFT88 BUB1 MARF1 CDADC1 NMT1 EIF3M DYNC1H1 SMAD9 KIF1C | 9.07e-09 | 1321 | 102 | 19 | 27173435 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | KIFBP NCKAP1 CENPF TRRAP ADAR TRIP10 PGM3 POLR3A CCT6A SMARCA4 DNAH8 DYNC1H1 | 1.11e-06 | 704 | 102 | 12 | 29955894 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | NCKAP1 ACTB CARS1 ACTG1 PFDN2 DNAJC7 ADAR ACTR2 POLR3A CCT6A SMARCA4 EIF3M DYNC1H1 | 1.23e-06 | 847 | 102 | 13 | 35235311 |
| Pubmed | HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus. | 1.36e-06 | 8 | 102 | 3 | 25818806 | |
| Pubmed | 1.39e-06 | 187 | 102 | 7 | 26460568 | ||
| Pubmed | 2.90e-06 | 10 | 102 | 3 | 11839798 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KIFBP NCKAP1 DNAH10 CENPF TM9SF3 CARS1 ACTG1 DNAJC7 ADAR ACTR2 POLR3A CCT6A SMARCA4 ATM EIF3M DYNC1H1 | 3.96e-06 | 1425 | 102 | 16 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KIFBP NCKAP1 ACTBL2 KIF1B CARS1 IKBKG ACTG1 PFDN2 DNAJC7 GDI1 TRIP10 ACTR2 CCT6A NMT1 EIF3M DYNC1H1 | 5.16e-06 | 1455 | 102 | 16 | 22863883 |
| Pubmed | 6.67e-06 | 334 | 102 | 8 | 30425250 | ||
| Pubmed | 7.56e-06 | 451 | 102 | 9 | 36168627 | ||
| Pubmed | 7.88e-06 | 43 | 102 | 4 | 20876399 | ||
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 8.52e-06 | 2 | 102 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 8.52e-06 | 2 | 102 | 2 | 22366783 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10814522 | ||
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 8.52e-06 | 2 | 102 | 2 | 32588558 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27625340 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 3221869 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25953896 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31189758 | ||
| Pubmed | Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. | 8.52e-06 | 2 | 102 | 2 | 10487415 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22384028 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16225668 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20660191 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21502360 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 11857508 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 6686106 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 213279 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33334799 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 8.52e-06 | 2 | 102 | 2 | 21900491 | |
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 8.52e-06 | 2 | 102 | 2 | 19638415 | |
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 8.52e-06 | 2 | 102 | 2 | 3335520 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 9288906 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1577857 | ||
| Pubmed | The human growth hormone gene family: structure and evolution of the chromosomal locus. | 8.52e-06 | 2 | 102 | 2 | 6306568 | |
| Pubmed | The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development. | 8.52e-06 | 2 | 102 | 2 | 27558071 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 26583190 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32326615 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 8.52e-06 | 2 | 102 | 2 | 23756437 | |
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 8.52e-06 | 2 | 102 | 2 | 8482333 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29265728 | ||
| Pubmed | Genomic cloning and chromosomal localization of the mouse Mab21l2 locus. | 8.52e-06 | 2 | 102 | 2 | 10516425 | |
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 8.52e-06 | 2 | 102 | 2 | 22246323 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 2837653 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 8.52e-06 | 2 | 102 | 2 | 32506774 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19079347 | ||
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 8.52e-06 | 2 | 102 | 2 | 20847274 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28202068 | ||
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 9373155 | ||
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 17411366 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 1.09e-05 | 15 | 102 | 3 | 16824795 | |
| Pubmed | 1.13e-05 | 47 | 102 | 4 | 15537664 | ||
| Pubmed | 1.62e-05 | 17 | 102 | 3 | 12464179 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | THOC7 CENPF ACTBL2 TM9SF3 ACTB ADAR GDI1 ACTR2 FAM83H CCT6A SMARCA4 NMT1 EIF3M DYNC1H1 | 1.85e-05 | 1257 | 102 | 14 | 36526897 |
| Pubmed | Hedgehog signaling is required for pituitary gland development. | 1.94e-05 | 18 | 102 | 3 | 11152636 | |
| Pubmed | Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. | 1.97e-05 | 111 | 102 | 5 | 21163940 | |
| Pubmed | THOC7 KIFBP ACTBL2 TM9SF3 IKBKG MAB21L2 DNAJC7 ACTR2 CDKAL1 PGM3 POLR3A CCT6A ATM EIF3M DYNC1H1 | 1.98e-05 | 1440 | 102 | 15 | 30833792 | |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 2.06e-05 | 112 | 102 | 5 | 20473970 | |
| Pubmed | Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. | 2.55e-05 | 3 | 102 | 2 | 9245787 | |
| Pubmed | Boosting ATM activity alleviates aging and extends lifespan in a mouse model of progeria. | 2.55e-05 | 3 | 102 | 2 | 29717979 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11994274 | ||
| Pubmed | Impact of altered actin gene expression on vinculin, talin, cell spreading, and motility. | 2.55e-05 | 3 | 102 | 2 | 7646816 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 21319186 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 2.55e-05 | 3 | 102 | 2 | 10704292 | |
| Pubmed | Angiostatin and plasminogen share binding to endothelial cell surface actin. | 2.55e-05 | 3 | 102 | 2 | 15746964 | |
| Pubmed | Actin Is Crucial for All Kinetically Distinguishable Forms of Endocytosis at Synapses. | 2.55e-05 | 3 | 102 | 2 | 27840001 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 2.55e-05 | 3 | 102 | 2 | 22403730 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17192268 | ||
| Pubmed | Molecular basis for G-actin binding to RPEL motifs from the serum response factor coactivator MAL. | 2.55e-05 | 3 | 102 | 2 | 19008859 | |
| Pubmed | Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin. | 2.55e-05 | 3 | 102 | 2 | 39195208 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24457965 | ||
| Pubmed | Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. | 2.55e-05 | 3 | 102 | 2 | 14595650 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 38970714 | ||
| Pubmed | Functional molecular complexes of human N-formyl chemoattractant receptors and actin. | 2.55e-05 | 3 | 102 | 2 | 8228254 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 9651520 | ||
| Pubmed | CTGF/Hcs24 interacts with the cytoskeletal protein actin in chondrocytes. | 2.55e-05 | 3 | 102 | 2 | 12470643 | |
| Pubmed | Chromosomal localization of the human placental lactogen-growth hormone gene cluster to 17q22-24. | 2.55e-05 | 3 | 102 | 2 | 7072716 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 6865942 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 23404705 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24413084 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 2.64e-05 | 118 | 102 | 5 | 27377895 | |
| Pubmed | 3.00e-05 | 60 | 102 | 4 | 19075228 | ||
| Pubmed | 3.13e-05 | 21 | 102 | 3 | 21571225 | ||
| Pubmed | 3.20e-05 | 61 | 102 | 4 | 19875381 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NCKAP1 ACTBL2 ACTB MTMR1 PFDN2 DNAJC7 ADAR GDI1 ACTR2 PHKA1 CCT6A NMT1 DYNC1H1 | 3.21e-05 | 1149 | 102 | 13 | 35446349 |
| Pubmed | ACTB ACTG1 PANX1 DNAJC7 ADAR ACTR2 CDKAL1 POLR3A PIK3C3 BUB1 MARF1 SMARCA4 DYNC1H1 | 3.80e-05 | 1168 | 102 | 13 | 19946888 | |
| Pubmed | 4.11e-05 | 65 | 102 | 4 | 22496869 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | NCKAP1 KIF1B ACTG1 PFDN2 DNAJC7 FAM83H CCT6A LRP2 NMT1 DYNC1H1 KIF1C | 4.25e-05 | 853 | 102 | 11 | 28718761 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 4.38e-05 | 564 | 102 | 9 | 21565611 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | KIFBP NCKAP1 RBL1 TM9SF3 MTMR1 TRRAP ADAR ESRP2 SMARCA4 DYNC1H1 SMAD9 | 4.43e-05 | 857 | 102 | 11 | 25609649 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 4.95e-05 | 573 | 102 | 9 | 28330616 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 15009185 | ||
| Pubmed | The formin-homology-domain-containing protein FHOD1 enhances cell migration. | 5.09e-05 | 4 | 102 | 2 | 12665555 | |
| Pubmed | TRPM7, a novel regulator of actomyosin contractility and cell adhesion. | 5.09e-05 | 4 | 102 | 2 | 16407977 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17669420 | ||
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 5.09e-05 | 4 | 102 | 2 | 7704034 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 16179592 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 6893015 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 26711340 | ||
| Pubmed | The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. | 5.09e-05 | 4 | 102 | 2 | 20663956 | |
| Interaction | YWHAQ interactions | CCP110 NCKAP1 TRPM7 KIF1B ACTB ACTG1 PFDN2 PFKFB2 MAB21L2 SIRT6 ACTR2 FAM83H CCT6A ZNF106 PIK3C3 PIK3CB DYNC1H1 SMAD9 KIF1C | 2.51e-06 | 1118 | 101 | 19 | int:YWHAQ |
| Interaction | POTEE interactions | 5.02e-06 | 134 | 101 | 7 | int:POTEE | |
| Interaction | MAP3K4 interactions | 5.30e-06 | 88 | 101 | 6 | int:MAP3K4 | |
| Interaction | POTEJ interactions | 6.17e-06 | 52 | 101 | 5 | int:POTEJ | |
| Interaction | BCL7B interactions | 8.27e-06 | 95 | 101 | 6 | int:BCL7B | |
| Interaction | PDCL3 interactions | 1.11e-05 | 100 | 101 | 6 | int:PDCL3 | |
| Interaction | ACTR3 interactions | 2.29e-05 | 305 | 101 | 9 | int:ACTR3 | |
| Interaction | ARHGAP12 interactions | 2.32e-05 | 68 | 101 | 5 | int:ARHGAP12 | |
| Interaction | EP400 interactions | 3.94e-05 | 184 | 101 | 7 | int:EP400 | |
| Interaction | SRCAP interactions | 4.32e-05 | 127 | 101 | 6 | int:SRCAP | |
| Interaction | COBL interactions | 4.52e-05 | 78 | 101 | 5 | int:COBL | |
| Interaction | CORO1B interactions | 5.16e-05 | 192 | 101 | 7 | int:CORO1B | |
| Interaction | CSNK2A2 interactions | RBL1 KIF1B MTMR1 SIRT6 TRRAP POLR3A CCT6A ZNF106 IFT88 PIK3C3 SMARCA4 EIF3M KIF1C | 6.09e-05 | 718 | 101 | 13 | int:CSNK2A2 |
| Interaction | FBXL5 interactions | 8.98e-05 | 47 | 101 | 4 | int:FBXL5 | |
| Interaction | ABTB1 interactions | 1.12e-04 | 19 | 101 | 3 | int:ABTB1 | |
| Interaction | TRIM28 interactions | SETD1A ZNF383 KIFBP NCKAP1 CENPF ACTB SIRT6 TRRAP ADAR GDI1 TRIP10 PGM3 POLR3A CCT6A PIK3C3 SMARCA4 ATM DNAH8 DYNC1H1 | 1.18e-04 | 1474 | 101 | 19 | int:TRIM28 |
| Interaction | KIF26B interactions | 1.34e-04 | 52 | 101 | 4 | int:KIF26B | |
| Interaction | UNC45A interactions | 1.51e-04 | 228 | 101 | 7 | int:UNC45A | |
| Interaction | POTEF interactions | 1.51e-04 | 228 | 101 | 7 | int:POTEF | |
| Interaction | TMOD1 interactions | 1.61e-04 | 161 | 101 | 6 | int:TMOD1 | |
| Cytoband | 16q22.1 | 1.11e-04 | 110 | 102 | 4 | 16q22.1 | |
| GeneFamily | Actins | 2.07e-04 | 6 | 68 | 2 | 929 | |
| GeneFamily | Growth hormone family | 2.07e-04 | 6 | 68 | 2 | 1175 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 3.85e-04 | 8 | 68 | 2 | 831 | |
| GeneFamily | Dyneins, axonemal | 1.83e-03 | 17 | 68 | 2 | 536 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.35e-03 | 23 | 68 | 2 | 662 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-06 | 182 | 102 | 6 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.94e-06 | 182 | 102 | 6 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_DC1|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.51e-06 | 193 | 102 | 6 | 42775588e788c330aade07e54b208f1c2eea3ab3 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 6.02e-06 | 196 | 102 | 6 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 6.76e-06 | 200 | 102 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | (5)_Plasma-(5)_Plasmablast|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.76e-06 | 200 | 102 | 6 | bba54e9acc7514e123de083a4eb49e7bcdb3dac3 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 150 | 102 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.47e-05 | 161 | 102 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.58e-05 | 162 | 102 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 164 | 102 | 5 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-05 | 169 | 102 | 5 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 172 | 102 | 5 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 175 | 102 | 5 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | droplet-Lung-21m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 175 | 102 | 5 | 6751ee4b312d7f87275f2c35e5878cfc3be3ebe3 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 176 | 102 | 5 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.30e-05 | 176 | 102 | 5 | 1f8d5a48fedbb4c86272c9b5a0f1ef573350357b | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-05 | 177 | 102 | 5 | f360f7099570d248531897b96e0de282e58f59e9 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 177 | 102 | 5 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Neuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.48e-05 | 90 | 102 | 4 | 840f93af13b5c4dd0eb4132c76f017f97a107e28 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.60e-05 | 178 | 102 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 179 | 102 | 5 | dabecd283c1f0f71a66b804c99be8bd48ea36e35 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 179 | 102 | 5 | 4166c4e1a8748a79ac6a11fd0b97c5344be2321b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.90e-05 | 180 | 102 | 5 | ce2fc270f9d9110c2544083f61936b0b7d3b7eb3 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-05 | 180 | 102 | 5 | de87503d9caac3ebc80ab8090c1a9ee5a925b2a0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.06e-05 | 181 | 102 | 5 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 182 | 102 | 5 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 6.55e-05 | 184 | 102 | 5 | 057c6c2f570914fa4af84682589a86b61547d6c9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.72e-05 | 185 | 102 | 5 | 282b3de8850f3c21704339e8d8737b432a43441a | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.72e-05 | 185 | 102 | 5 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 6.72e-05 | 185 | 102 | 5 | 9d3168c7f0b1d739f78b368969cf5c77ce202b97 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.72e-05 | 185 | 102 | 5 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 186 | 102 | 5 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Proliferative_AT2_Progenitor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.07e-05 | 187 | 102 | 5 | e986901f5a1e09cbc9ba37e3c62845ff90ceda95 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.62e-05 | 190 | 102 | 5 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | b65383e256b04122500b742caeed0b807793851e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.62e-05 | 190 | 102 | 5 | 89095d3e023269d89c82e3a73550f869e3f34201 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.81e-05 | 191 | 102 | 5 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.40e-05 | 194 | 102 | 5 | b4f4730a53a63118c02a3692a9c52adfd7201598 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 194 | 102 | 5 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-GC_B_(I)|lymph-node_spleen / Manually curated celltypes from each tissue | 8.82e-05 | 196 | 102 | 5 | 32d54c0b487f00c4f8bd765462e484da8a6625c9 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.03e-05 | 197 | 102 | 5 | ffc55028052311ed8d173a2db1a9f664391fe8d8 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.03e-05 | 197 | 102 | 5 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | COVID-19_Severe-PLT_0|COVID-19_Severe / Disease Group and Platelet Clusters | 9.03e-05 | 197 | 102 | 5 | dbdeefa72d10f2c5f75ad5aac6f31a892d4e94a9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.25e-05 | 198 | 102 | 5 | 06888fe2d42ac66ac12157608becd42764e0d034 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.27e-05 | 103 | 102 | 4 | e28236a064a7c86e99e7e2edb1eb777f6034a9b4 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.47e-05 | 199 | 102 | 5 | 624a807fae0a080a4e6755dcb374c25b6f2d2cfe | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.47e-05 | 199 | 102 | 5 | 0c743e4e88cbd2ca72e5161ca22a3e974b26f9b4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Cycling_T|lymph-node_spleen / Manually curated celltypes from each tissue | 9.47e-05 | 199 | 102 | 5 | 28fc342d2d178ce33203a78eb9eedae54fa9c916 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.69e-05 | 200 | 102 | 5 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 200 | 102 | 5 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 116 | 102 | 4 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| Drug | NSC350593 | ACTRT3 ACTBL2 ACTB ACTG1 HPSE2 SIRT6 ADAR ADORA1 ART3 PIK3C3 PIK3CB | 2.86e-08 | 269 | 100 | 11 | CID000004364 |
| Drug | cryptotanshinone | 3.30e-08 | 43 | 100 | 6 | CID000160254 | |
| Drug | HU-211 | 3.91e-08 | 114 | 100 | 8 | CID000107778 | |
| Drug | ATP betaS | 4.09e-08 | 162 | 100 | 9 | CID005311341 | |
| Drug | AC1L1IZ2 | ACTRT3 TRPM7 ACTBL2 KIF1B ACTB ACTG1 SIRT6 GH2 ADORA1 ART3 DYNC1H1 | 9.90e-08 | 304 | 100 | 11 | CID000004795 |
| Drug | D-myo-inositol 1,4-bisphosphate | 1.03e-07 | 86 | 100 | 7 | CID000000805 | |
| Drug | bistheonellide A | 1.13e-07 | 11 | 100 | 4 | CID006441172 | |
| Drug | Viroisin | 1.13e-07 | 11 | 100 | 4 | CID000119538 | |
| Drug | BFDGE | 1.69e-07 | 12 | 100 | 4 | CID000091511 | |
| Drug | AC1OAGKW | 1.84e-07 | 193 | 100 | 9 | CID006857413 | |
| Drug | azaspiracid | 1.93e-07 | 30 | 100 | 5 | CID006451158 | |
| Drug | AC1OAGGW | 2.82e-07 | 203 | 100 | 9 | CID006857364 | |
| Drug | kabiramide C | 3.39e-07 | 14 | 100 | 4 | CID005288658 | |
| Drug | triphosphoinositide | ACTRT3 TRPM7 ACTB IKBKG ACTG1 SIRT6 TRRAP ART3 PIK3CB SMARCA4 | 3.49e-07 | 273 | 100 | 10 | CID009543520 |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 3.72e-07 | 34 | 100 | 5 | CID000001312 | |
| Drug | orthovanadate | ACTRT3 TRPM7 ACTBL2 KIF1B ACTB ACTG1 SIRT6 PGM3 ART3 PIK3C3 PIK3CB DYNC1H1 | 4.68e-07 | 435 | 100 | 12 | CID000061672 |
| Drug | Ro-1724 | 5.60e-07 | 110 | 100 | 7 | CID000005087 | |
| Drug | 5'-N-ethylcarboxamidoadenosine | 1.01e-06 | 174 | 100 | 8 | CID000104795 | |
| Drug | Nsc687160 | 1.02e-06 | 18 | 100 | 4 | CID005459290 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | ACTRT3 ACTB IKBKG ACTG1 SIRT6 FGF18 PHKA1 ART3 PIK3C3 PIK3CB | 1.05e-06 | 308 | 100 | 10 | CID000001915 |
| Drug | tolytoxin | 1.29e-06 | 19 | 100 | 4 | CID006440827 | |
| Drug | 5'IATR | 1.29e-06 | 19 | 100 | 4 | CID000074997 | |
| Drug | 6-trans-leukotriene B4 | 1.45e-06 | 247 | 100 | 9 | CID000000169 | |
| Drug | AC1L1IZE | 1.82e-06 | 131 | 100 | 7 | CID000004799 | |
| Drug | tetramethylrhodamine isothiocyanate | 1.96e-06 | 47 | 100 | 5 | CID004123009 | |
| Drug | NSC312786 | 1.98e-06 | 21 | 100 | 4 | CID000329495 | |
| Drug | AC1L8NVR | 1.98e-06 | 21 | 100 | 4 | CID000384633 | |
| Drug | Mgamp-pnp | 1.98e-06 | 21 | 100 | 4 | CID005311323 | |
| Drug | Fm 4-64 | 2.85e-06 | 90 | 100 | 6 | CID002733635 | |
| Drug | AC1L1H7K | 3.43e-06 | 144 | 100 | 7 | CID000004010 | |
| Drug | Nbd-Ph | 3.48e-06 | 24 | 100 | 4 | CID004682184 | |
| Drug | chelerythrine | ACTRT3 TRPM7 ACTBL2 ACTB ACTG1 SIRT6 ADORA1 ART3 PIK3C3 PIK3CB | 3.93e-06 | 357 | 100 | 10 | CID000002703 |
| Drug | AC1OAGFB | ACTRT3 TRPM7 ACTBL2 ACTB IKBKG ACTG1 SIRT6 TRRAP TRIP10 ART3 PIK3C3 PIK3CB | 4.35e-06 | 539 | 100 | 12 | CID006857345 |
| Drug | AC1L1KC5 | ACTRT3 RBL1 ACTBL2 ACTB IKBKG ACTG1 HPSE2 SIRT6 ADORA1 ART3 PIK3C3 PIK3CB | 4.51e-06 | 541 | 100 | 12 | CID000005428 |
| Drug | BADGE | 5.63e-06 | 58 | 100 | 5 | CID000002286 | |
| Drug | glycerophosphoinositol | 7.84e-06 | 62 | 100 | 5 | CID000167572 | |
| Drug | oryzalin | 8.49e-06 | 63 | 100 | 5 | CID000029393 | |
| Drug | vanadyl | 8.52e-06 | 307 | 100 | 9 | CID000061671 | |
| Drug | AC1L1BDQ | 1.14e-05 | 173 | 100 | 7 | CID000001394 | |
| Drug | AC1L1HS4 | 1.15e-05 | 32 | 100 | 4 | CID000004267 | |
| Drug | enantio-PAF-C16 | 1.24e-05 | 244 | 100 | 8 | CID000002499 | |
| Drug | 2-arachidonoylglycerol (2-AG | 1.43e-05 | 119 | 100 | 6 | CID000001541 | |
| Drug | N,N'-p-phenylenedimaleimide | 1.47e-05 | 34 | 100 | 4 | CID000076765 | |
| Drug | astragaloside A | 1.47e-05 | 34 | 100 | 4 | CID000122690 | |
| Drug | Hypertensin II | ACTRT3 TRPM7 ACTBL2 ACTB ACTG1 SIRT6 DNAJC7 ART3 PIK3C3 PIK3CB | 1.94e-05 | 429 | 100 | 10 | CID000025476 |
| Drug | calphostin C | ACTRT3 ACTBL2 ACTB ACTG1 SIRT6 ADORA1 SCGB1D1 ART3 PIK3C3 PIK3CB | 2.02e-05 | 431 | 100 | 10 | CID000002533 |
| Drug | 8-cyclopentyltheophylline | 2.31e-05 | 38 | 100 | 4 | CID000001917 | |
| Drug | AC1LADJ6 | 2.37e-05 | 130 | 100 | 6 | CID000486032 | |
| Drug | Rp-cAMPS | 2.40e-05 | 194 | 100 | 7 | CID006426631 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 1823_DN | |
| Drug | wiskostatin | 2.56e-05 | 39 | 100 | 4 | CID000448668 | |
| Drug | CGS 15943 | 2.56e-05 | 39 | 100 | 4 | CID000002690 | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 4826_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 3768_DN | |
| Drug | AGEPC | 2.75e-05 | 356 | 100 | 9 | CID000461545 | |
| Drug | plakin | 3.08e-05 | 82 | 100 | 5 | CID000018752 | |
| Drug | epsilon-ATP | 3.13e-05 | 41 | 100 | 4 | CID000162262 | |
| Drug | SF6847 | 3.13e-05 | 41 | 100 | 4 | CID000005614 | |
| Drug | N6-(phenylisopropyl)adenosine | 3.13e-05 | 41 | 100 | 4 | CID000034507 | |
| Drug | AC1NRBPQ | 3.19e-05 | 137 | 100 | 6 | CID005288569 | |
| Drug | KT5926 | 3.45e-05 | 42 | 100 | 4 | CID000122126 | |
| Drug | N-acetyl-S-geranylgeranyl-L-cysteine | 3.45e-05 | 42 | 100 | 4 | CID000002067 | |
| Drug | AC1L8FNU | 4.16e-05 | 44 | 100 | 4 | CID000425429 | |
| Drug | losartan | 4.39e-05 | 378 | 100 | 9 | CID000003961 | |
| Drug | BAPTA-AM | 4.57e-05 | 293 | 100 | 8 | CID000002293 | |
| Drug | fluorescein isothiocyanate | 4.73e-05 | 147 | 100 | 6 | CID000018730 | |
| Drug | ML-9 | 4.73e-05 | 147 | 100 | 6 | CID000004217 | |
| Drug | carbachol | CDKN3 ACTRT3 TRPM7 ACTBL2 ACTB IKBKG ACTG1 SIRT6 ADORA1 ART3 PIK3C3 PIK3CB | 4.88e-05 | 688 | 100 | 12 | CID000002551 |
| Drug | 17alpha-estradiol | CDKN3 SLC4A8 CYP2C18 ACTRT3 ACTBL2 ACTB ACTG1 HPSE2 PPARD GH1 GH2 BMPR1B PIK3C3 PIK3CB LRP2 SMARCA4 ATM | 4.96e-05 | 1303 | 100 | 17 | CID000000450 |
| Drug | withaferin A | 4.96e-05 | 46 | 100 | 4 | CID000265237 | |
| Drug | AC1L22RD | 5.10e-05 | 91 | 100 | 5 | CID000065183 | |
| Drug | C18:1n-7 | 5.37e-05 | 92 | 100 | 5 | CID000122325 | |
| Drug | cnicin | 5.37e-05 | 92 | 100 | 5 | CID000091176 | |
| Drug | thryroxine | 5.65e-05 | 302 | 100 | 8 | CID000000853 | |
| Drug | mDia | 5.66e-05 | 93 | 100 | 5 | CID000128346 | |
| Drug | GTP[S] | CDKN3 ACTRT3 TRPM7 ACTBL2 ACTB IKBKG ACTG1 SIRT6 EDDM3A ADORA1 ART3 | 5.76e-05 | 591 | 100 | 11 | CID000001764 |
| Drug | NpCaM | 5.88e-05 | 48 | 100 | 4 | CID000122259 | |
| Drug | DMPX | 5.88e-05 | 48 | 100 | 4 | CID000099562 | |
| Drug | AC1Q6LQU | 5.88e-05 | 48 | 100 | 4 | CID000072380 | |
| Drug | AC1L1GXW | 5.95e-05 | 94 | 100 | 5 | CID000003891 | |
| Drug | H-1152P | 6.13e-05 | 154 | 100 | 6 | CID000448043 | |
| Drug | DFMO | 6.36e-05 | 155 | 100 | 6 | CID000003009 | |
| Drug | telmisartan | 6.58e-05 | 96 | 100 | 5 | CID000065999 | |
| Drug | NSC-351907 | 6.88e-05 | 229 | 100 | 7 | CID000004016 | |
| Drug | tetramethylrhodamine | 6.91e-05 | 50 | 100 | 4 | CID000065219 | |
| Drug | AC1L1BHQ | 7.07e-05 | 230 | 100 | 7 | CID000001444 | |
| Drug | m2-19 | 7.57e-05 | 19 | 100 | 3 | CID000079129 | |
| Drug | monochloramine | 8.07e-05 | 52 | 100 | 4 | CID000025423 | |
| Drug | 9-beta-D-arabinofuranosylguanine | CDKN3 NCKAP1 ACTRT3 ACTBL2 ACTB IKBKG ACTG1 SIRT6 ADAR EDDM3A ADORA1 ART3 SNTG1 | 8.15e-05 | 843 | 100 | 13 | CID000000765 |
| Drug | Formyl | 8.76e-05 | 238 | 100 | 7 | CID000123370 | |
| Drug | beryllium fluoride | 9.20e-05 | 103 | 100 | 5 | CID000024589 | |
| Drug | AC1L1GZB | 9.60e-05 | 167 | 100 | 6 | CID000003908 | |
| Drug | 3-methylhistidine | 1.01e-04 | 55 | 100 | 4 | CID000064969 | |
| Drug | PTK/ZK | 1.08e-04 | 56 | 100 | 4 | CID000151193 | |
| Drug | imatinib | 1.17e-04 | 430 | 100 | 9 | CID000005291 | |
| Drug | dihydrocytochalasin B | 1.24e-04 | 58 | 100 | 4 | CID000003064 | |
| Drug | arabinosyladenine | ACTRT3 ACTBL2 ACTB CARS1 IKBKG ACTG1 SIRT6 ADAR ADORA1 ART3 PIK3C3 PIK3CB | 1.28e-04 | 762 | 100 | 12 | CID000000191 |
| Drug | forskolin from Coleus forskohlii | CDKN3 ACTRT3 ACTBL2 ACTB IKBKG ACTG1 SIRT6 ADAR EDDM3A ADORA1 BMPR1B ART3 PIK3C3 PIK3CB | 1.36e-04 | 1013 | 100 | 14 | CID000003413 |
| Drug | cryptolepine | 1.37e-04 | 23 | 100 | 3 | ctd:C024015 | |
| Drug | 6-chloromelatonin | 1.37e-04 | 23 | 100 | 3 | CID000001858 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.91e-06 | 8 | 97 | 3 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.91e-06 | 8 | 97 | 3 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.91e-06 | 8 | 97 | 3 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.91e-06 | 8 | 97 | 3 | DOID:14004 (implicated_via_orthology) | |
| Disease | Microcephaly | 2.84e-06 | 67 | 97 | 5 | C0025958 | |
| Disease | intestinal atresia (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 4.06e-06 | 10 | 97 | 3 | DOID:13832 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome | 1.07e-05 | 2 | 97 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 1.07e-05 | 2 | 97 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 1.07e-05 | 2 | 97 | 2 | C1853623 | |
| Disease | Gastric Adenocarcinoma | 1.47e-05 | 45 | 97 | 4 | C0278701 | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 1.06e-04 | 5 | 97 | 2 | DOID:0060872 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.16e-04 | 447 | 97 | 8 | C3714756 | |
| Disease | Craniofacial Abnormalities | 1.69e-04 | 156 | 97 | 5 | C0376634 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 2.22e-04 | 7 | 97 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | Uveoretinal Coloboma | 2.22e-04 | 7 | 97 | 2 | C4554007 | |
| Disease | cancer (implicated_via_orthology) | 2.63e-04 | 268 | 97 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Idiopathic pulmonary hypertension | 3.79e-04 | 9 | 97 | 2 | C0152171 | |
| Disease | Congenital ocular coloboma (disorder) | 3.79e-04 | 9 | 97 | 2 | C0009363 | |
| Disease | dipeptidase 2 measurement | 4.73e-04 | 10 | 97 | 2 | EFO_0801528 | |
| Disease | Congenital neurologic anomalies | 4.73e-04 | 10 | 97 | 2 | C0497552 | |
| Disease | Cranioschisis | 4.73e-04 | 10 | 97 | 2 | C0265541 | |
| Disease | Sensory hearing loss | 5.77e-04 | 11 | 97 | 2 | C1691779 | |
| Disease | nervous system disease (implicated_via_orthology) | 6.91e-04 | 12 | 97 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Prenatal Exposure Delayed Effects | 6.91e-04 | 12 | 97 | 2 | C0033054 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 8.15e-04 | 13 | 97 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 9.49e-04 | 14 | 97 | 2 | C1955869 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 9.49e-04 | 14 | 97 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | Cortical Dysplasia | 9.49e-04 | 14 | 97 | 2 | C0431380 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.25e-03 | 16 | 97 | 2 | C3203102 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 1.41e-03 | 17 | 97 | 2 | cv:C0270914 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.76e-03 | 19 | 97 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 1.76e-03 | 19 | 97 | 2 | C2936783 | |
| Disease | prostate cancer (is_marker_for) | 1.78e-03 | 156 | 97 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Arthrogryposis | 2.16e-03 | 21 | 97 | 2 | C0003886 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.37e-03 | 22 | 97 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Schizophrenia | 2.52e-03 | 883 | 97 | 9 | C0036341 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.59e-03 | 23 | 97 | 2 | C1335177 | |
| Disease | Sensorineural Hearing Loss (disorder) | 2.59e-03 | 23 | 97 | 2 | C0018784 | |
| Disease | lung adenocarcinoma | 2.64e-03 | 174 | 97 | 4 | EFO_0000571 | |
| Disease | Dystonia | 2.89e-03 | 86 | 97 | 3 | C0013421 | |
| Disease | Kidney Diseases | 3.09e-03 | 88 | 97 | 3 | C0022658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKKRVEDAYILTCNV | 221 | P40227 | |
| VMEDFLKRIECYKVT | 186 | O60825 | |
| KEYKCDVLMREKEAL | 46 | Q14507 | |
| RYLEEVMKVPVYCTK | 336 | O95394 | |
| ECKMEYLKEREEFRK | 76 | Q7Z7K0 | |
| VEQVVMYCKEKLIRG | 231 | O43683 | |
| KCKIEFLTGEFIYRM | 386 | Q86XM0 | |
| VIKCEFEKVISMEYM | 166 | P30542 | |
| KIVEDIKESFCYVAM | 206 | Q9BYD9 | |
| NSIMKCDVDIRKDLY | 281 | Q562R1 | |
| SIMKCDVDIRKDLYA | 281 | P60709 | |
| SIMKCDVDIRKDLYA | 281 | P63261 | |
| RDFIDCFLIKMEQEK | 261 | P10632 | |
| CKQERIKEYEMLFLV | 231 | Q9BWV3 | |
| SYEDMREIVCIKKLR | 436 | O00238 | |
| ETVRMIKEKLCYVGY | 211 | P61160 | |
| RVRIKGAESEKYICM | 96 | O60258 | |
| RCKEDEKYLQTIMDA | 316 | Q13613 | |
| FYDFKIIMKDEIIPC | 51 | Q8NAB2 | |
| LKYMLEVEIGRTTCK | 86 | O76096 | |
| AEEKMKVNYVFICFR | 126 | O95190 | |
| MKVFCEVLEELYKKV | 1 | Q8NG48 | |
| MVKVILREYKDECLD | 1046 | Q9UJ55 | |
| YDTEKKMVEINFLCV | 236 | P30419 | |
| TKDVCMVFYSRDAKI | 1401 | O60333 | |
| CMIRQVDKVESFKYS | 91 | P46020 | |
| FVIDAVRTKMVYCKI | 311 | Q7L2H7 | |
| IKMIETKYREGREVC | 126 | P11801 | |
| LCFSERYKEMVQKIV | 5011 | Q5CZC0 | |
| LKEVDETRKCYRMVG | 61 | Q9UHV9 | |
| IKLACMDTYVVEVLV | 186 | Q8NH05 | |
| KTVVKMFVVIYDLRD | 966 | Q32MH5 | |
| DKECDIMDTFKLYIT | 3546 | Q96JB1 | |
| QVRIKGKETEFYLCM | 96 | O76093 | |
| DLKMQAVKEICYEVA | 746 | O43896 | |
| SILACKIEMVDYKEE | 1376 | O60449 | |
| EFLMCKFQEARKLVE | 91 | Q9Y6K9 | |
| YKLMSDKRTCVDIDE | 3141 | P98164 | |
| CSDLKFIMEELDKVY | 136 | Q96RD7 | |
| CYIDGRVVKVMDFLK | 336 | Q8WWQ2 | |
| EEYKIACLLMVFVAV | 991 | Q9Y2A7 | |
| IRNSECKKEVDFSMY | 1401 | A2PYH4 | |
| CLKILEEKTAAYDIM | 146 | Q4JDL3 | |
| SLKYARVKEVEEMCK | 2146 | Q13315 | |
| LMIKKEACYFRRETT | 51 | O95760 | |
| LTICYFAIGDREKMK | 311 | Q13099 | |
| MAEIKEKICDYLFNV | 296 | P55265 | |
| CEVYRQSLEKLEEKM | 1556 | P49454 | |
| LETFCMKLRDEEYEK | 201 | Q5THR3 | |
| MEMKREYCVADFKRV | 331 | Q5VV42 | |
| LKPTEKIFMSYEEIC | 476 | Q6MZW2 | |
| KIFMSYEEICPQREK | 481 | Q6MZW2 | |
| ERKALEMVEKCLDKY | 476 | Q96BT3 | |
| MEEYEKFCEKSLARI | 1 | O43303 | |
| DKCSYRDVVKMIADT | 141 | Q9Y586 | |
| DKMEECVKLTSLYLF | 1476 | Q9Y4F3 | |
| TDFEKRDFRKVVFCM | 151 | Q99615 | |
| TALREELKKVCQEMY | 2176 | Q14204 | |
| RDFIDCFLIKMEQEK | 261 | P33260 | |
| ETTCNDIKDIYKRMA | 411 | P31150 | |
| ADIVYCEELIDLKMI | 36 | Q9NX74 | |
| MRKEKRVYSRFEVFC | 1126 | Q6ZRV2 | |
| EIMEELTTCLKNYRK | 121 | Q16667 | |
| VEAVMGYCDVFREIK | 3241 | Q8IVF4 | |
| KVLAFFETDMERRCK | 431 | Q96EK5 | |
| YCEKAPKIDFKMEII | 601 | A5PLK6 | |
| YYVEKKKRFCRMVVA | 21 | Q9NUP7 | |
| EQIIKYLCKSEEFMD | 211 | Q8TBZ9 | |
| YCMNITDIDDKIIKR | 91 | P49589 | |
| TIRMKLEYEKCERSC | 101 | Q03181 | |
| DKCSYRDVVKMVADT | 141 | Q13394 | |
| YEECKDLIKFMLRNE | 331 | P0DPF3 | |
| YEECKDLIKFMLRNE | 331 | Q6P3W6 | |
| CAFYIMAKVTKEERT | 846 | P28749 | |
| AEKTFSVYEIMCKIL | 331 | Q9NSN8 | |
| YLMVEFRCVKCDDKE | 216 | Q8NEB9 | |
| VEKFLETCRDKYMRA | 1011 | O14802 | |
| KVEYVIKCDMSALQR | 991 | P51532 | |
| VFVRKVMDLCFSKRE | 986 | Q2Y0W8 | |
| KVMKERYVEVVPCST | 541 | Q9H6T0 | |
| VILSELYVEKCKYMD | 766 | P42338 | |
| MFVEECAKCKTQYVR | 136 | Q8N6T7 | |
| VVKDAYETAKMLCEQ | 196 | Q15120 | |
| KDMCRKYGEVEEVEI | 111 | O15047 | |
| GFEVVYELTKMCTIR | 401 | O15198 | |
| EVKKCVDTMAYEKRV | 61 | O95968 | |
| LEDQCTEYMAKVIEK | 396 | Q969K4 | |
| IFEYECKKKIDVMPI | 356 | Q8IZF2 | |
| VRVCLELTKYSQEMK | 96 | Q15642 | |
| CFRKDMDKVETFLRI | 191 | P01242 | |
| KKEVYEIELCQREIM | 91 | Q8NA42 | |
| CFRKDMDKVETFLRI | 191 | P01241 | |
| REMENYEKIYKEIEC | 76 | Q6I9Y2 | |
| IKFKDDVMPATYCEI | 96 | Q9HD45 | |
| VMILDFYVDSICSVK | 281 | Q8TAD4 | |
| RSYIMSCEEELKRIK | 1306 | O60346 | |
| EEKALRAKEYECFVM | 421 | Q8N3L3 | |
| RAKEYECFVMKIGRL | 426 | Q8N3L3 | |
| AAEECREKLIKEMDY | 131 | A6NGJ6 | |
| AAEECREKLIKEMDY | 131 | A6NI03 | |
| LYMCVKITCEEKATE | 106 | Q7Z3V5 | |
| VLIDAIAICMAYEEK | 1091 | Q9Y4A5 | |
| KVMVTACLDKFVRVY | 1751 | Q9H2Y7 | |
| EESMAKALVACKIYR | 646 | Q96QT4 | |
| FDDEYLKCTDRMEIK | 36 | Q13508 |